Myelitis Clinical Trials

99 recruitingLast updated: June 18, 2026

There are 99 actively recruiting myelitis clinical trials across 34 countries. Studies span Phase 2, Not Applicable, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Montpellier, France. Updated daily from ClinicalTrials.gov.


Myelitis Trials at a Glance

99 actively recruiting trials for myelitis are listed on ClinicalTrialsFinder across 6 cities in 34 countries. The largest study group is Phase 2 with 19 trials, with the heaviest enrollment activity in Boston, New York, and Montpellier. Lead sponsors running myelitis studies include Tongji Hospital, PATH, and Alexion Pharmaceuticals, Inc..

Treatments under study

About Myelitis Clinical Trials

Looking for clinical trials for Myelitis? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Myelitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Myelitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 99 trials

Recruiting

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Myasthenia GravisAutoimmune EncephalitisMultiple Sclerosis+3 more
Third Affiliated Hospital, Sun Yat-Sen University100 enrolled1 locationNCT07653984
Recruiting

Patient-Centered Assessment of Symptoms and Outcomes

Myalgic Encephalomyelitis/Chronic Fatigue SyndromeCancerFatigue+5 more
National Center for Complementary and Integrative Health (NCCIH)692 enrolled1 locationNCT03952624
Recruiting

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

Neuromyelitis OpticaMultiple SclerosisDemyelinating Autoimmune Diseases, CNS
Icahn School of Medicine at Mount Sinai170 enrolled1 locationNCT05982925
Recruiting
Phase 3

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

Neuromyelitis Optica Spectrum DisorderNMOSD
Hoffmann-La Roche8 enrolled13 locationsNCT05199688
Recruiting
Not Applicable

Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.

Osteomyelitis
Biocomposites Ltd139 enrolled1 locationNCT07270380
Recruiting

Mirragen Diabetic Foot Ulcer Study

Diabetic Foot UlcerOsteomyelitis Chronic
The University of Texas Health Science Center at San Antonio20 enrolled1 locationNCT06598241
Recruiting
Not Applicable

Evaluation of the Evolution of Patient Care Within the Spinal Pathology Department

Spinal StenosisSpinal FractureVertebral Metastasis+1 more
University Hospital, Bordeaux15,000 enrolled1 locationNCT07627282
Recruiting

A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME/CFS

Chronic Fatigue SyndromeEncephalomyelitis
Mayo Clinic40 enrolled1 locationNCT07551999
Recruiting
Phase 4

Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

Osteomyelitis TibiaTibial FracturesOpen Tibia Fracture
Wake Forest University Health Sciences484 enrolled14 locationsNCT05421741
Recruiting
Phase 3

Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Neuromyelitis Optica Spectrum Disorders (NMOSD)
Tianjin Medical University General Hospital198 enrolled1 locationNCT07420296
Recruiting
Phase 1

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Neuromyelitis Optica Spectrum Disorder (NMOSD)Multiple Sclerosis (MS)Myasthenia Gravis (MG)+4 more
Tongji Hospital6 enrolled1 locationNCT07526493
Recruiting
Phase 2

Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama

Poliomyelitis
PATH1,532 enrolled3 locationsNCT05654467
Recruiting
Not Applicable

RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
University of Alberta200 enrolled3 locationsNCT06933173
Recruiting
Phase 2

A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.

OsteomyelitisPressure Ulcer, Stage IV
Biocomposites Ltd60 enrolled9 locationsNCT06283979
Recruiting
Phase 2Phase 3

A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

Neuromyelitis Optica Spectrum Disorders
Shanghai Jiaolian Drug Research and Development Co., Ltd132 enrolled51 locationsNCT06413654
Recruiting
Phase 1

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Neuromyelitis Optica Spectrum Disorder (NMOSD)+6 more
Polina Stepensky120 enrolled1 locationNCT07085676
Recruiting
Phase 3

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

Optic NeuritisMyelitisMyelitis, Transverse
Mayo Clinic382 enrolled31 locationsNCT07100990
Recruiting

CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure

Osteomyelitis
BONESUPPORT AB128 enrolled1 locationNCT06555848
Recruiting

Prospective Study of Sinonasal and Skull-base Tumours Management

Nasal NeoplasmNasal Neoplasm BenignSkull Base Neoplasms+3 more
University Medical Centre Ljubljana120 enrolled1 locationNCT05607888
Recruiting
Not Applicable

High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network

Acute Disseminated EncephalomyelitisEncephalitis Autoimmune
University Hospital, Angers20 enrolled8 locationsNCT06863974